Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists

Author(s): Jan Honegr, Ondrej Soukup, Rafael Dolezal, David Malinak, Marek Penhaker, Roman Prymula, Kamil Kuca

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 29 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Toll like receptors (TLRs) are a family of transmembrane proteins which play a key role in innate immunity. When TLRs come into contact with a potential threat, they initiate a signaling cascade leading to release of cytokines and chemokines, maturation of antigen presenting cells and immune activation. Molecules which can activate TLRs may be utilized for vaccine development and act as vaccine adjuvants. Adjuvants can facilitate production of more effective vaccines based on antigens produced by recombinant techniques or by DNA vaccines, which are often poorly immunogenic since they lack the endogenous innate immunostimulatory components of the pathogen. In this paper the structural properties of such prospective compounds are thoroughly discussed.

Keywords: Immunologic adjuvants, TLR, vaccines, SMIP, innate immunity, drug design, targeting, Toll-like receptor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [3306 - 3325]
Pages: 20
DOI: 10.2174/0929867322666150821094634
Price: $65

Article Metrics

PDF: 79
PRC: 1